Home

Publications library


  • Home
    • /
  • Publication Library Listing

Publications

Therapeutic Areas
Modeling & Meta-Analyses
Newest to Oldest

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

Authors: M J H G Simons, P M Machielsen, J A Spoorendonk, T Ignacio, P B Drost, T Jacobs, F E de Jongh

The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis

Authors: B Guthrie, G Rogers, S Livingstone, D R Morales, P Donnan, S Davis, J H Youn, R Hainsworth, A Thompson, K Payne

Using the online elicitation of personal utility functions approach to derive a patient-based 5-level version of EQ-5D value set: A study in 122 patients with rheumatic diseases from Germany

Authors: P Schneider, K Blankart, J Brazier, B van Hout, N Devlin

Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ-5D-5L value functions on societal, group and individual level

Authors: P Schneider, N Devlin, B van Hout, J Brazier

Using the Online Elicitation of Personal Utility Functions (OPUF) approach to derive a patient-based EQ-5D-5L value set: a study in 122 patients with rheumatic diseases from Germany

Authors: P Schneider, K Blankart, J Brazier, B van Hout, N Devlin

Long-term outcomes of Eladocagene Exuparvovec compared with standard of care in aromatic l-Amino Acid Decarboxylase (AADC) deficiency: A modelling study

Authors: C L Simons, W-L Hwu, R Zhang, M J H G Simons, M Bergkvist, C Bennison

Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)

Authors: V McLaughlin, A Alsumali, R Liu, R Klok, E C Martinez, I Nourhussein, D Bernotas, J Chevure, C Pausch, J D O Pena, D Lautsch & M M Hoeper

Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer

Authors: J Garside, Q Shen, B Westermayer, M van de Ven, S Kroep, V Chirikov, I Juhasz-Böss

Cost-effectiveness of terlipressin for hepatorenal syndrome: The United States hospital perspective

Authors: J A Carter, X Huang, K Jamil, S Corman, V Ektare, J Niewoehner

Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective

Authors: N Dhanji, T Cristina Decimoni, M T D Dyer , J R May, G van de Wetering, S Petersohn, K Nickel, A Silva, D Q B Muniz, A P C D Oliveira
View older
Home